Chestnut Global Partners Completes First Global Study of DuPont Employee Assistance Program Workplace Outcomes

Share Article

DuPont Integrated Health Services (DuPont) uses Chestnut Global Partners’ Workplace Outcome Suite to quantify the effectiveness of its Employee Assistance Program providers in locations around the world.

Chestnut Global Partners

The WOS brings EAP in line with the data-driven approaches that are changing the way organizations conduct all phases of their business.

The Commercial Science Division of Chestnut Global Partners (CGP), a provider of culturally-aware employee assistance and wellness programs to companies worldwide, today announced the results of a year-long study of the employee assistance programs (EAP) that DuPont provides to its workplace locations in Latin America, Asia, Europe and the U.S. DuPont used CGP's Workplace Outcome Suite (WOS), a short, psychometrically tested and validated instrument specifically designed for quick and reliable assessment of EAP effectiveness. The WOS contains five items that lie at the heart of understanding the positive effects of EAP and Health/Wellness Coaching in the workplace: absenteeism, presenteeism, work engagement, life satisfaction and workplace distress. DuPont uses several different vendors across the globe and each vendor had the WOS translated into the appropriate languages.

The DuPont study examined if and to what degree EAP interventions improved their employees' workplace functioning. The survey was administered to 1,140 DuPont employees from locations in four global regions before seeking EAP counsel, and 90 days after. Results from the WOS indicated a post-test 82 percent improvement in absenteeism, a 29 percent improvement in presenteeism, a 16 percent improvement in engagement, a 27 percent improvement in life satisfaction and a 21 percent decrease in workplace distress.

"Too few organizations hold their EAPs accountable as many are unaware that tools such as the WOS exist to measure their efficacy, which is to say their true value," said Matt Mollenhauer, VP of Operations for CGP. "The DuPont global study is the first of its kind, providing the company with reliable outcomes data in all the regions they do business, which is the best way to gauge how the programs are performing in each country. With DuPont taking the lead, we're hopeful that other multinational companies -- indeed any company engaging an EAP -- will be proactive in insisting that the WOS or a similar tool be used in holding EAP providers accountable for results and making sure the programs are in actuality improving the health and productivity of their workforce."

“The WOS brings EAP in line with the data-driven approaches that are changing the way organizations conduct all phases of their business—from product design to customer service, to marketing and talent acquisition. We now have a set of metrics that measure the key elements of the emotional environment of the workplace. This approach translates improved productivity into quantifiable results and makes the business case for investing in EAP services,” according to Paul Heck, global manager, Employee Assistance and WorkLife Services, DuPont.

About Chestnut Global Partners

Chestnut Global Partners (CGP) is a behavioral health organization based in Bloomington, IL that offers a full range of culturally aware employee assistance and related workplace services. CGP combines EAP with wellness, disability, high risk maternity, employee safety and compliance management programs, designed to promote employee well-being, improve performance and reduce absenteeism.

Chestnut Global Partners serves companies in over 140 countries, including Brazil, China, India, Mexico, Russia, Central Europe and North American Native American Tribes and Casinos. Chestnut Global Partners’ Division of Commercial Science develops and deploys scientific assessment technologies, outcome measures, and analytical methodologies so that EAPs, wellness companies, disease management entities and purchasers the world over can determine the effects and/or worth of their programs. For more, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Charles Epstein
(561) 470-0965
Email >

Dr. Dave Sharar
Follow us on
Visit website